Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 11, 2025
Brainstorm: A Case of Granulomatous EncephalitisPatrick Benoit, Stephanie Wang, Catherine Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2017
A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque RetinaAntoine Chaffiol, Romain Caplette, Céline Jaillard, et al.
Neurobiology of Disease|January 15, 2005
ABCA2 is a strong genetic risk factor for early-onset Alzheimer's diseaseSandrine Macé, Emmanuelle Cousin, Sylvain Ricard, et al.
Nature Medicine|November 12, 2024
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infectionsPatrick Benoit, Noah Brazer, Mikael de Lorenzi-Tognon, et al.
The American Journal of Pathology|October 7, 2004
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic modelCaty Casas, Nicolas Sergeant, Jean-Michel Itier, et al.
Journal of Medical Virology|April 14, 2021
Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory-developed assaysAnnie-Claude Labbé, Patrick Benoit, Sarah Gobeille Paré, et al.
Alzheimer'S Research & Therapy|November 30, 2018
SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)Laurent Pradier, Véronique Blanchard-Brégeon, Andrees Bohme, et al.
Nature Communications|November 12, 2024
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discoveryJessica Karielle Tan, Venice Servellita, Doug Stryke, et al.
American Journal of Ophthalmology|March 6, 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5Maria A Parker, Laura R Erker, Isabelle Audo, et al.
Emerging Infectious Diseases|April 3, 2025
Metagenomic Identification of Fusarium solani Strain as Cause of US Fungal Meningitis Outbreak Associated with Surgical Procedures in Mexico, 2023Charles Y Chiu, Venice Servellita, Mikael de Lorenzi-Tognon, et al.
Pageof 2